AMP v Myriad

The U.S. Supreme Court heard oral arguments yesterday in the case of Association for Molecular Pathology v. Myriad Genetics.  The questions raised in this patent explore the boundaries of patent eligible subject matter.  Much of the discussion focused on the nature of cDNA which is created through a process that includes the isolation of a portion of DNA.  The oral argument can be found here.  Molecular Pathology v Myriad